CureVac Comes Around

Janssen and Global Partners to Discontinue Phase 3 Mosaico HIV Vaccine Clinical Trial | Johnson & Johnson

Independent, scheduled review of Phase 3 Mosaico study finds investigational vaccine regimen lacks efficacy in preventing HIVNo vaccine-related safety issues identified

Tissue adaptation and clonal segregation of human memory T cells in barrier sites - Nature Immunology

Farber and colleagues examine the phenotypic, transcriptomic, clonal, and functional differences between tissue-resident T cells in various barrier tissue sites relative to T cells in lymphoid organs and circulation in humans.

Molecular fate-mapping of serum antibody responses to repeat immunization - Nature

Serum antibody responses to sequential homologous booster vaccines derive overwhelmingly from primary cohort B cells at the expense of de novo responses; this ‘primary addiction’ can be overcome by boosting with variant antigens.

Is COVID Immunity Hung Up on Old Variants?

You never forget your first time with SARS-CoV-2.

EUROPE: 11 PhD positions in MSCA DN project RBP-ReguNET

Eleven PhD positions are available in the Marie Sklodowska-Curie Doctoral Network “RBP-ReguNET – Deconstructing and Rewiring RNA-RBP regulatory networks”.